| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
DBK
|
32.66 | 61.4B | 9.12 | 0.79 | — | — | — | 74 | 68 | 59.90 | +61.7% | 79 | 1.66 |
|
CBK
|
38.62 | 41.7B | 15.82 | 1.22 | — | — | — | 61 | 43 | 38.32 | -0.5% | 89 | 0.10 |
|
DWS
|
72.85 | 14.6B | 21.94 | 1.95 | 10.01 | — | — | 51 | 38 | 55.54 | -17.8% | 71 | 0.02 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.